CollPlant Biotechnologies reported revenue of $0.07M and net income of -$3.10M for the quarter ended Mar 2026, down 96.4% year over year. This income statement covers 34 quarters of results from Dec 2017 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||||
| Revenue | 0.69M | 0.14M | 0.31M | 0.07M | 0.11M | 0.06M | 0.43M | 10.18M | 0.04M | 0.30M | 0.10M | 0.25M | 0.00M | 0.16M | 2.06M | 0.18M | 0.08M | 0.06M | 0.07M | |||||||||||||||
| Cost of RevenueCost of Rev | 0.43M | 0.14M | 0.55M | 0.03M | 0.04M | 0.26M | 0.06M | 0.33M | 0.61M | 0.28M | 0.77M | 0.55M | 0.54M | 0.27M | 0.27M | 0.19M | 0.19M | 0.27M | 0.19M | 0.32M | ||||||||||||||
| Gross Profit | 0.26M | -0.00M | -0.24M | 0.04M | 0.02M | -0.15M | -0.00M | 0.11M | 9.57M | -0.23M | -0.47M | -0.45M | -0.29M | -0.27M | -0.11M | 1.87M | -0.01M | -0.19M | -0.13M | -0.24M | ||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 1.90M | 1.91M | 2.19M | 2.24M | 2.60M | 2.78M | 2.64M | 2.10M | 2.57M | 2.69M | 3.11M | 2.41M | 2.70M | 2.87M | 2.54M | 2.10M | 2.01M | 2.09M | 1.98M | 1.68M | ||||||||||||||
| Selling, General & AdministrativeSG&A | 1.42M | 1.18M | 1.38M | 1.56M | 1.61M | 1.54M | 2.04M | 1.52M | 1.32M | 1.67M | 1.48M | 1.48M | 1.42M | 1.41M | 1.32M | 1.41M | 1.16M | 1.23M | 1.04M | 1.19M | ||||||||||||||
| Other Operating ExpensesOther Opex | -3.71M | 3.25M | 0.25M | 0.15M | ||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 3.33M | 3.09M | 3.57M | 0.09M | 4.21M | 4.31M | 7.92M | 3.63M | 3.89M | 4.37M | 4.59M | 3.88M | 4.12M | 4.27M | 4.12M | 3.52M | 3.17M | 3.31M | 3.17M | 2.87M | ||||||||||||||
| Operating IncomeOp. Inc | -3.06M | -3.09M | -3.80M | 3.77M | -4.18M | -4.47M | -4.68M | 3.52M | 5.68M | -4.60M | -5.07M | 4.33M | 4.41M | -4.54M | -3.97M | -1.65M | 3.18M | -3.51M | -3.15M | -3.12M | ||||||||||||||
| EBIT | -3.06M | -3.09M | -3.80M | 3.77M | -4.18M | -4.47M | -4.68M | 3.52M | 5.68M | -4.60M | -5.07M | 4.33M | 4.41M | -4.54M | -3.97M | -1.65M | 3.18M | -3.51M | -3.15M | -3.12M | ||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | -0.01M | -0.01M | ||||||||||||||||||||||||||||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | ||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.07M | 0.07M | 0.03M | |||||||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.04M | -0.04M | ||||||||||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.03M | 0.02M | 0.03M | -0.09M | -0.10M | 0.09M | 0.28M | -0.20M | 0.09M | 0.23M | 0.38M | 0.13M | 0.20M | 0.22M | 0.10M | 0.20M | -0.17M | 0.02M | -0.06M | 0.02M | ||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||
| EBT | -2.98M | -3.02M | -3.77M | 3.77M | -4.18M | -4.47M | -4.68M | 3.52M | 5.68M | -4.60M | -5.07M | 4.33M | 4.41M | -4.54M | -3.97M | -1.65M | 3.18M | -3.51M | -3.15M | -3.12M | ||||||||||||||
| Profit After TaxPAT | 3.04M | -3.08M | -3.77M | 3.86M | 4.29M | -4.38M | 29.45M | 3.71M | 5.76M | -4.38M | -4.69M | 4.20M | 4.21M | -4.33M | -3.88M | -1.45M | 3.35M | -3.48M | -3.21M | -3.10M | ||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -2.98M | -3.02M | -3.77M | 3.77M | -4.18M | -4.47M | -4.68M | 3.52M | 5.68M | -4.60M | -5.07M | 4.33M | 4.41M | -4.54M | -3.97M | -1.65M | 3.18M | -3.51M | -3.15M | -3.12M | ||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -2.98M | -3.02M | -3.77M | 3.77M | -4.18M | -4.47M | -4.68M | 3.52M | 5.68M | -4.60M | -5.07M | 4.33M | 4.41M | -4.54M | -3.97M | -1.65M | 3.18M | -3.51M | -3.15M | -3.12M | ||||||||||||||
| Income towards Parent CompanyParent Net Inc | -2.98M | -3.02M | -3.77M | 3.77M | -4.18M | -4.47M | -4.68M | 3.52M | 5.68M | -4.60M | -5.07M | 4.33M | 4.41M | -4.54M | -3.97M | -1.65M | 3.18M | -3.51M | -3.15M | -3.12M | ||||||||||||||
| Net Income towards Common StockholdersNet Income | -2.98M | -3.02M | -3.77M | 3.77M | -4.18M | -4.47M | -4.68M | 3.52M | 5.68M | -4.60M | -5.07M | 4.33M | 4.41M | -4.54M | -3.97M | -1.65M | 3.18M | -3.51M | -3.15M | -3.12M | ||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||
| EPS (Basic) | -4.33 | -4.38 | -3.79 | 3.78 | -4.20 | -4.48 | -4.24 | 3.19 | 5.15 | -4.17 | -4.45 | 3.80 | 3.87 | -3.99 | -3.47 | -1.44 | 2.77 | -3.06 | -2.58 | -2.55 | ||||||||||||||
| EPS (Diluted) | -4.33 | -4.38 | -3.15 | 3.15 | -3.50 | -3.73 | -4.24 | 3.19 | 5.15 | -4.17 | -4.45 | 3.80 | 3.87 | -3.99 | -3.47 | -1.44 | 2.77 | -3.06 | -2.58 | -2.55 | ||||||||||||||
| Shares Outstanding | 0.69M | 0.69M | 1.00M | 1.00M | 1.00M | 1.00M | 1.10M | 1.10M | 1.10M | 1.10M | 1.14M | 1.14M | 1.14M | 1.14M | 1.15M | 1.15M | 1.15M | 1.15M | 1.22M | 1.22M | ||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.69M | 0.69M | 1.20M | 1.20M | 1.20M | 1.20M | 1.10M | 1.10M | 1.10M | 1.10M | 1.14M | 1.14M | 1.14M | 1.14M | 1.15M | 1.15M | 1.15M | 1.15M | 1.22M | 1.22M | ||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 1.08M | 1.12M | 1.15M | 1.15M | 1.28M | |||||||||||||||||||||||||||||
| EBITDA | -3.06M | -3.09M | -3.80M | 3.77M | -4.18M | -4.47M | -4.68M | 3.52M | 5.68M | -4.60M | -5.07M | 4.33M | 4.41M | -4.54M | -3.97M | -1.65M | 3.18M | -3.51M | -3.15M | -3.12M | ||||||||||||||
| Interest ExpensesInt Expense | -0.01M | -0.01M |